The U.S. FDA has issued two notices: seeking public comments on regulations regarding tobacco retailer training programs and sales restrictions

Aug.22.2025
The U.S. FDA has issued two notices: seeking public comments on regulations regarding tobacco retailer training programs and sales restrictions
On August 22, the U.S. FDA issued two notices soliciting public comments on regulations regarding tobacco retailer training programs and restrictions on tobacco sales. Both notices provide a 60-day public comment period under the Paperwork Reduction Act, aiming to protect public health, especially that of children and adolescents, by regulating retailer behavior and restricting tobacco sales.

Key points: 

·Tobacco retailer training program: The FDA plans to establish standards to regulate tobacco retailer training programs, covering topics such as federal laws restricting the sale, advertising, and promotion of tobacco products. It is estimated that approximately 239,100 tobacco retailers will need to develop training programs that conform to the guidelines. 

·Regulations on tobacco sales: These regulations aim to protect children and adolescents by restricting the sale and distribution of cigarettes and smokeless tobacco. Tobacco product manufacturers, distributors, and retailers are required to notify the FDA at least 30 days before using any advertising or labeling media not listed in the regulations. 

·Public comment period: Both notices provide a 60-day public comment period, during which the public can submit feedback electronically or in writing.

 


 

According to the FDA website's announcement on August 22nd, the U.S. FDA has issued two notifications in the Federal Register, one regarding tobacco retailer training programs and the other seeking public input on regulations limiting tobacco sales.

 

Tobacco Retailer Training Program (Docket No. FDA-2025-N-2653)

 

The FDA is considering establishing standards to regulate tobacco retailer training programs. These programs should cover federal laws regarding the sale, advertising, and promotion of tobacco products, the health and economic impacts of tobacco use, and policies prohibiting sales to minors. The FDA estimates that around 239,100 tobacco retailers will need to develop training programs that comply with these guidelines. The program will also include requirements such as written tests, annual training updates, and record-keeping. The FDA projects that the annual burden of developing training programs, establishing written policies, and conducting internal compliance checks for information collection activities will be 1,992,500 hours, with a record-keeping burden of 191,280 hours.

 

Regulations restricting tobacco sales (Docket No. FDA-2025-N-2652)

 

The regulation aims to protect children and adolescents by restricting the sale and distribution of both traditional and smokeless tobacco products. It requires tobacco product manufacturers, distributors, and retailers to notify the FDA at least 30 days before using any advertising or labeling medium not specifically listed in the regulation. The FDA anticipates approximately four respondents to submit alternative advertising notifications each year, with an average burden of 1 hour per notification. Since 2022, the FDA has received a total of 12 such notifications.

 

Public Opinion Consultation

 

Both notices are in accordance with the Paperwork Reduction Act of 1995, which requires a 60-day period for public comment. The public can submit electronic comments through the Federal eRulemaking Portal website, or submit written comments through mail, hand delivery, or courier. For comments containing confidential information, two copies must be submitted - one with the confidential information included, and the other with the confidential information removed for public viewing. The FDA will assess and adjust information collection activities based on public feedback.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China’s top tobacco regulator has issued a directive aimed at preventing excess capacity and curbing “involution-style” competition in the e-cigarette sector. The notice tightens investment controls, formalizes verified capacity management and requires exporters to submit compliance proof for destination markets, signaling a push toward higher industry concentration and stricter cross-border oversight.
Special Report
Feb.13
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
BAT Japan to launch two new VELO nicotine pouch flavours in February
BAT Japan to launch two new VELO nicotine pouch flavours in February
BAT Japan will roll out two new VELO nicotine pouch variants from Feb. 2, 2026: Smooth Peppermint Medium and Breezy Mango Intense. The products will be sold via the official glo & VELO online store, the glo Store Ginza and nationwide tobacco retail channels in Japan.
Jan.23 by 2FIRSTS.ai
BREAKING: China Brings Nicotine Pouches Under Tobacco Monopoly Regulation, Signaling Major Shift for Oral Products
BREAKING: China Brings Nicotine Pouches Under Tobacco Monopoly Regulation, Signaling Major Shift for Oral Products
China has for the first time issued clear regulatory rules for nicotine pouches and other oral nicotine products, formally classifying them under the tobacco monopoly alongside cigarettes and tobacco, ending a long-standing legal grey zone and laying the regulatory groundwork for their potential domestic launch.
Jan.09 by Alan Zhao | 2Firsts Perspectives
Product | Lost Vape launches “4D portable shisha” device with 3,800mAh battery and up to 80W output
Product | Lost Vape launches “4D portable shisha” device with 3,800mAh battery and up to 80W output
E-cigarette brand Lost Vape has recently listed its open-system DTL device, the ASTARA, on its official website. The company markets the product as “The First 4D Portable Shisha Experience,” highlighting a 360-degree display and audio features. The ASTARA has also appeared on some online sales channels in markets including the UK and Germany.
Feb.03 by 2FIRSTS.ai
Heated tobacco brand DIITO launches in Mongolia
Heated tobacco brand DIITO launches in Mongolia
A new heat-not-burn (HNB) brand, DIITO, has commenced promotional activities in the Mongolian market. The device features an integrated display panel and supports dual heating modes, "RELAX" and "RUSH." Investigations reveal that DIITO’s local promotion closely overlaps with RELX’s official distribution channels. Furthermore, the DIITO trademark is held by the UK-based REAZEN TECH LIMITED, a company that also manages the e-cigarette brand FASTA.
Jan.16 by 2FIRSTS.ai